Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


The Mayor appoints Professor Stephen Caddick to the London Enterprise Panel

2 January 2014

We are pleased to confirm that Professor Stephen Caddick has been appointed to the new position on the LEP for a representative of London’s Higher Education sector.

Professor Caddick is Vice-Provost (Enterprise) at University College London and is responsible for leading UCL's enterprise agenda. He is the inaugural Chair of the League of European Research Universities (LERU) Enterprise and Innovation Community.  Professor Caddick also served on the Review Panel of the Wilson Review of Business-University Collaboration, is a member of the Government’s Tech City Advisory Panel and already a Member of the LEP’s Digital Creative, Science & Technology Working Group.

Read: london.gov.uk